SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS THROUGH 3 YEARS: LONG-TERM RESULTS OF TWO RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDIES

被引：0

作者：

Kvien, T. K. ^{[1
]}

Deodhar, A. ^{[2
]}

Gossec, L. ^{[3
]}

Conaghan, P. G. ^{[4
]}

Strand, V. ^{[5
]}

Ostergaard, M. ^{[6
]}

Williams, N. ^{[7
]}

Porter, B. ^{[8
]}

Gandhi, K. ^{[8
]}

Jugl, S. ^{[9
]}

机构：

[1] Diakonhjemmet Hosp, Oslo, Norway

[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[3] UPMC Univ Paris 06, Paris, France

[4] Univ Leeds, Leeds, W Yorkshire, England

[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[6] Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark

[7] RTI Hlth Solut, Durham, NC USA

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Novartis Pharma AG, Basel, Switzerland

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

363

引用

页码：S9 / S9

页数：1

共 50 条

[41] Alicaforsen Enema in Chronic Pouchitis: Results of a Phase 3 Randomized, Double-blind, Placebo-controlled Trial
Feagan, Brian
Lindsay, James
Rogler, Gerhard
Moran, Gordon
Varawalla, Nermeen
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S364 - S364
[42] Impact of Fremanezumab on Disability Severity in Patients With Episodic and Chronic Migraine: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
Nagy, Abraham J.
McAllister, Peter
Cohen, Joshua M.
Ning, Xiaoping
Campos, Verena Ramirez
Du, Evelyn
Ashina, Messoud
NEUROLOGY, 2021, 96 (15)
[43] IMPACT OF FREMANEZUMAB ON DISABILITY SEVERITY IN PATIENTS WITH EPISODIC AND CHRONIC MIGRAINE: POOLED RESULTS OF 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDIES
Nagy, Abraham J.
McAllister, Peter
Cohen, Joshua M.
Ning, Xiaoping
Campos, Verena Ramirez
Du, Evelyn
Ashina, Messoud
CEPHALALGIA, 2020, 40 : 93 - 94
[44] Improvements in Headache-Related Disability With Fremanezumab in Patients ≥60 Years of Age With Migraine: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Joshi, S.
Cohen, J. M.
Ning, X.
Ramirez-Campos, V
Janka, L.
Ashina, M.
HEADACHE, 2020, 60 : 20 - 20
[45] Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial
Duygu Şilte Karamanlioğlu
Ilknur Aktas
Feyza Unlu Ozkan
Meryem Kaysin
Nuray Girgin
Rheumatology International, 2016, 36 : 653 - 661
[46] Efficacy and Safety of Wenbu Zhibi Granule in Patients with Ankylosing Spondylitis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Zhang, Helou
Yu, Yang
Du, Weibin
Wu, Fengqing
Zheng, Yang
Ren, Conglin
Zhou, Huateng
Wu, Yijiang
Gao, Yang
Ren, Weifan
Quan, Renfu
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[47] Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial
Karamanlioglu, Duygu Silte
Aktas, Ilknur
Ozkan, Feyza Unlu
Kaysin, Meryem
Girgin, Nuray
RHEUMATOLOGY INTERNATIONAL, 2016, 36 (05) : 653 - 661
[48] SECUKINUMAB REDUCES SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A 16-WEEK, RANDOMIZED PLACEBO-CONTROLLED PHASE 3 TRIAL
Kivitz, Alan
Blanco, Ricardo
Maradiaga, Marco
Sieper, Joachim
Tahir, Hasan
Andersson, Mats
Readie, Aimee
Porter, Brian
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 141 - 141
[49] Efficacy and safety of AK111, in patients with active ankylosing spondylitis: results from a randomized, double-blind, placebo-controlled, phase II clinical study
Li, Zhanguo
Xia, Yu
Wang, Max
Li, Baiyong
Ni, Xiang
Wang, Guoqin
Zhang, Li
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[50] Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
Brandt, J
Khariouzov, A
Listing, J
Haibel, H
Sörensen, H
Grassnickel, L
Rudwaleit, M
Sieper, J
Braun, J
ARTHRITIS AND RHEUMATISM, 2003, 48 (06): : 1667 - 1675

← 1 2 3 4 5 →